Top Story

Childhood-onset craniopharyngioma linked to high mortality

December 19, 2014

Craniopharyngioma appears to be linked to excess mortality, particularly in women and in patients with childhood-onset disease, according to recent findings.

In the nationwide, population-based study, researchers identified 307 patients with craniopharyngioma (151 men) from the Swedish National Patient Registry and the Swedish Cancer Registry to determine rates of morbidity and mortality for both childhood- and adult-onset disease.

Carolyn Crandall In the Journals

Moderate to severe menopausal vasomotor symptoms increased hip fracture risk

December 18, 2014
Women with moderate-to-severe vasomotor symptoms during menopause showed lower bone mineral density and higher rates of hip fracture than women without the symptoms…
In the Journals

Diabetes, metabolic disorders linked to urban stressors

December 18, 2014
Diabetes and metabolic disorders may be more common among people in developing nations who live in cities vs. those who remain in rural areas because of increased stress…
Health Care Legislative and Regulatory Update

New year, new code: How to get paid for chronic care management in 2015, part 1

December 18, 2014
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s…
FDA News

FDA announces members of its Pharmacy Compounding Committee

December 18, 2014
The FDA has announced the roster of its new Pharmacy Compounding Advisory Committee, the agency announced in a press release. The 14-member committee includes a lineup…
More News Headlines »
CME
low no

Low- and No-Calorie Sweeteners in Weight Management: What Do You Need to Know?

This activity is supported by an educational grant from the American Beverage Association.

The use of low- and no-calorie sweeteners continues to grow as consumers continue to purchase foods and beverages…
More »
Meeting News Coverage Video
thumbnail for video 3890508474001

Lenvatinib, sorafenib may significantly impact treatment of differentiated thyroid cancer

November 13, 2014
Marcia S. Brose, MD, PhD, associate professor at the University of Pennsylvania and director of the thyroid cancer…
More »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »